South San Francisco, CA (PRWEB) May 21, 2009
At AACC 2009 in Chicago, IL, Tosoh Bioscience (Booth #3140) will be featuring advancements in immunoassay and HPLC testing. During the AACC 2009 Annual Meeting Show Dates (July 21 - 23), events from Tosoh Bioscience will include free educational seminars by David Plaut as well as Tosoh product demonstrations. Plaut's annual AACC educational seminars are eagerly anticipated as a source of pertinent information from immunoassay and HPLC testing. Also, Plaut provides immunoassay and HPLC case studies for reference. David Plaut will give free CDs of his seminar information to attendees.
There will also be excitement revolving around the Tosoh product line at AACC 2009, as Tosoh will be introducing a new analyzer for immunoassay testing: the AIA-2000 Automated Immunoassay Analyzer. With a throughput of 200 tests per hour, the AIA-2000 provides all the speed and flexibility necessary to excel in high throughput laboratory testing environments. Expanded functionality has been added to the system, improving laboratory workflow and increasing walk away time.
Also for Immunoassay testing, the AIA-360 is a sophisticated system that fits in any lab environment. With a footprint of 16 X 16 X 21 inches and weighing approximately 60 lbs., the AIA-360's compact design makes it ideal for physician office laboratories, work stations for small hospitals, STAT testing, such as cardiac panels, as well as a dedicated system for specialty testing. With a throughput of 36 tests per hour, the AIA-360 generates its first result in approximately 20 minutes. The cost effective system utilizes the same 10 minute ST reagents as Tosoh's larger systems, making it the perfect back-up analyzer.
Tosoh's AIA-600 II is a proven system and has earned the industry-wide reputation of high reliability for immunoassay testing. The analyzer provides big system features in a bench top analyzer. Fitting in just 30 inches of counter space, the AIA-600 II has a throughput of 60 results per hour including STAT assay results in ~18 minutes, making it an ideal solution for time-critical tests such as cardiac markers.
All Tosoh AIA immunoassay testing systems utilize the same Unit Dose Test Cup reagent format, ensuring consistent performance every time. With interchangeable reagents on all Tosoh systems, inventory management is easy and problem free. Transition from one system to another is seamless, ensuring consistent results and efficient, economical operation for the laboratory.
For HbA1c testing, Tosoh's G8 HPLC Analyzer provides one of the industry's lowest CVs of less than 2%. The NGSP certified instrument-reagent system utilizes the gold standard ion-exchange method for HbA1c testing to effectively monitor glycohemoglobin in diabetic patients. With a compact footprint of 21"w x 19"h x 20"d, the G8 fits easily in most laboratory environments. The G8 provides fast results with an HbA1c analysis time of only 1.6 minutes. Simple touch-screen operation, as well as automatic start-up and daily maintenance make the system extremely user-friendly.
The Tosoh G7 HPLC Analyzer can be used for both HbA1c and beta-thalassemia testing in one compact analyzer. The system provides beta-thalassemia results in less than 8 minutes with quantification of HbF and HbA2. Also, the NGSP certified G7 HPLC Analyzer delivers presumptive identification of HbS, C and D; as well as true separation of Labile and Stable A1c.
With the TRCRapid-160 (Research Use Only), Tosoh has responded to the growing need and acceptance of molecular diagnostic devices. This accurate and full-featured platform delivers accelerated real-time RNA amplification and detection by combining two innovative technologies - the isothermal TRC reaction and the unique INAF fluorescence probe. This technology features much lower reaction times than seen with traditional real-time PCR. This instrument has the potential to be used in many testing areas, such as infectious diseases, cancer markers and
In 2009, Tosoh Bioscience, Inc. is celebrating 20 years in the diagnostic industry. Started in 1989 as Tosoh Medics, Inc., the company is committed to providing quality diagnostic systems and priority service to laboratory customers. TBI has sustained double digit growth over the past 8 years, surpassing the industry growth of ~ 4%, with 2008 being the most successful year to date. Sales of Tosoh Bioscience analyzers and assays have grown consistently throughout the years.